Placeholder Banner

BIO Supporting Oxitec’s Experimental Use Permit (EUP) for Biotech Mosquito

September 30, 2021

The Biotechnology Innovation Organization (BIO) submits these comments in response to the U.S. Environmental Protection Agency’s (EPA) request for public input on the receipt of an application, 93167-EUP-2, from Oxitec Ltd requesting to amend and extend of an experimental use permit (EUP) for the OX5034 Aedes aegypti mosquitoes expressing tetracycline Trans-Activator Variant protein. The mosquitoes are proposed to be released in Florida and California to evaluate the efficacy of the mosquitoes as a tool for suppression of wild Aedes aegypti mosquito populations. The release would be an amendment and extension of an EUP authorized in April 2020.

Download Full Comments Below
BIO comments on Oxitec EUP
Discover More
On behalf of the U.S. Biostimulant Coalition (USBC), the Biological Products Industry Alliance (BPIA), the American Seed Trade Association (ASTA), the Biotechnology Innovation Organization (BIO), and the Humic Products Trade Association, we are…
The Biotechnology Innovation Organization (BIO) is the largest biotechnology trade association, representing approximately 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United…
The value of science and agricultural innovation cannot be understated. The adoption of biotechnology in agriculture and the development of biobased technologies contribute to food security, sustainability, and climate change solutions. Over the…